Turkish Version of Telehealth Usability Questionnaire (TUQ)
Investigation of the Turkish Validity and Reliability of the Telehealth Usability Questionnaire (TUQ)
1 other identifier
observational
170
1 country
2
Brief Summary
The Telehealth Usability Questionnaire (TUQ) was developed to evaluate the usability of telehealth applications and services. The Turkish validity and reliability study of the scale, originally in English, has not been conducted before. The aim of this study is to develop the Turkish version of the Telehealth Usability Questionnaire (TUQ), which is a new stability tool, and to report its reliability assessment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2021
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 12, 2021
CompletedFirst Submitted
Initial submission to the registry
March 14, 2021
CompletedFirst Posted
Study publicly available on registry
March 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 12, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 12, 2022
CompletedDecember 5, 2023
December 1, 2023
1.3 years
March 14, 2021
December 2, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Reliability and Validity of TUQ by Correlation Analysis.
with telehealth will be researched
12 month
Study Arms (2)
patients
patients who were used telehealth
health professional
health professional who were used telehealth.
Interventions
validity and reliability assessment of the Turkish version of the Telehealth Usability Questionnaire (TUQ)
Eligibility Criteria
The Turkish validity and reliability of the scale, which was created to evaluate the usability of the telehealth service for service users (patients) and providers (health professional), will be investigated.
You may qualify if:
- Participants will undergo screening to confirm eligibility, completion of initial screening form, and MMSE evaluation. Study subjects were enrolled with MMSE scores between 29-30, inclusive (healthy/control), 25-28, inclusive (mild cognitive impairment), and 10-24 (dementia).
You may not qualify if:
- Unable to complete computerized and standard pencil-and-paper based assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Irem Hüzmelilead
Study Sites (2)
Hatay Mustafa Kemal University
Hatay, Merkez, 31010, Turkey (Türkiye)
Online
Hatay, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Irem Huzmeli, Phd
Mustafa Kemal University
- PRINCIPAL INVESTIGATOR
Esra Dogru Huzmeli, Assoc Prof.
Mustafa Kemal University
- STUDY CHAIR
Mehmet Karadağ, Asist. Prof.
Mustafa Kemal University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 15 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Phd lecturer
Study Record Dates
First Submitted
March 14, 2021
First Posted
March 17, 2021
Study Start
March 12, 2021
Primary Completion
June 12, 2022
Study Completion
June 12, 2022
Last Updated
December 5, 2023
Record last verified: 2023-12